Galena Biopharma Inc. (GALE) Thursday said Mark Ahn, its President and Chief Executive Officer, has resigned from the company to pursue other goals. Mark Schwartz will take over the position, effective immediately.
Previously, Schwartz was Galena's Executive Vice President and Chief Operating Officer. He has over 30 years of experience in the biotechnology and life science industry. Before joining Galena, he had served in the roles of President and Chief Executive at Apthera Inc. and at Bayhill Therapeutics. He was also the President and CEO of Calyx Therapeutics, which expanded significantly, and completed key Phase 1 and Phase 2 international clinical trials of novel anti-inflammatory compounds during his tenure.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.